MedPath

A clinical trial to compare the efficacy of Ashwagandhadi Ghrita Nasya with Fluticasone Propionate nasal spray in Allergic Rhinitis

Phase 2/3
Not yet recruiting
Conditions
Other specified respiratory disorders. Ayurveda Condition: VATAJAPRATISYAYAH,
Registration Number
CTRI/2023/03/050540
Lead Sponsor
Dr Chiragdip Ranjitsing Deshmukh
Brief Summary

Vataja Pratishyaya (Allergic Rhinitis) is common disease in day to day practice and contemporary science does not have proper solution for treating the same. Around 80% of the patient pool coming to Otorhinolaryngologist belongs to allergic rhinitis. Treatment according to modern science is avoidance of allergens, administration of nasal decongestants, corticosteroids and antihistamines, this may relieve symptoms but may lead to certain side effects. Recurrences are quite common even after treatment. Hence effective management of allergic rhinitis is necessary.

Nasya is the choice of treatment in Ayurveda for Vataja Pratishyaya. Ashwagandhadi Ghrita has ingredients which are found to have anti-inflammatory, analgesic, antioxidant, antihistaminic and antiallergic properties. The study is planned to develop evidence based support for Ashwagandhadi Ghrita nasya in the management of Vataja Pratishyaya .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patient suffering from Kshawathu( sneezing), Nasa avarodha(nasal congestion), nasa kandu(nasal itching), nasa strava(nasal discharge), shiro gaurav(heaviness in head) and shwasa kashtata( difficulty in breathing).

Exclusion Criteria
  • Pregnant and lactating women 2.
  • Patients who need surgical and other intervention 3.
  • Patients suffering from bacterial or viral rhinitis 4.
  • Patients suffering from severe hypertension, malignancy, uncontrolled diabetes mellitus, heart disease and bronchial asthama.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Reduced SneezingEnrollment: day 0 | Final follow-up: day 7
2. Improvement in breathing due to clearing of nasal passage.Enrollment: day 0 | Final follow-up: day 7
3. Reduced Nasal itching.Enrollment: day 0 | Final follow-up: day 7
4. Reduced RhinorrheaEnrollment: day 0 | Final follow-up: day 7
5. Reduced frequency of Headache.Enrollment: day 0 | Final follow-up: day 7
Secondary Outcome Measures
NameTimeMethod
Improvement in sleep qualityEnrollment: day 0

Trial Locations

Locations (1)

Dr. D. Y. Patil college of Ayurveda and Research centre

🇮🇳

Pune, MAHARASHTRA, India

Dr. D. Y. Patil college of Ayurveda and Research centre
🇮🇳Pune, MAHARASHTRA, India
Dr Chiragdip Ranjitsing Deshmukh
Principal investigator
7709779541
dchirag8241@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.